News

The phase I dose-escalation trial is the first human study with MDX-1106 (also known as ONO-4538), a fully human anti-PD-1 antibody for the treatment of cancer, and is

The agreement is between Raptor Pharmaceutical, a subsidiary of Raptor Pharmaceuticals Corp, and Dr William Mobley, professor of neurology and neurological sciences at the Stanford School of Medicine

Under the new agreement, which replaces the existing 50/50 collaboration between the two companies, Archemix will be responsible for the discovery of short-acting aptamers targeting the coagulation cascade

Under the terms of this agreement, New England Biolabs (NEB) will also manufacture Solexa’s proprietary sequencing-by-synthesis polymerase. Solexa claims that its Genome Analysis System will enable researchers to

MK-0431A combines the novel approach to controlling blood sugar of Merck’s Januvia (sitagliptin phosphate), an investigational DPP-4 inhibitor, with metformin, a widely-prescribed medication for type 2 diabetes, in

Tavocept was originated and developed by BioNumerik. The initial development focus for the drug candidate has been as an investigational new drug to prevent or mitigate the peripheral

In their complaint, Repligen and The Massachusetts Institute of Technology (MIT) allege that ImClone’s production of Erbitux infringes a US patent that covers certain genetic elements that increase

In the EU, products targeted to treat disorders that affect fewer than five in 10,000 people are eligible for orphan designation. Orphan status will provide significant advantages and

The H5N1 avian influenza virus is rapidly evolving into antigenically distinct clades, or families. H5N1 clade 1 flu viruses were identified in Vietnam in 2003; by last winter,